Independent confirmation of the significance of CCND2 came from the Cancer Dependency Map project, where genome-wide RNAi screens identified CCND2 as an essential gene in the two 2 RUNX1/RUNX1T-expressing AML cell lines within a total of 501 cancer cell lines [60]. The gene discussed is CCND2; the disease is acute myeloid leukemia.